Breast Implants Market Size was valued at USD 2.62 Billion in 2023. The Global Breast Implants industry is projected to grow from USD 2.79 Billion in 2024 to USD 4.67 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.65% during the forecast period (2024 - 2032). An increase in breast surgery awareness, increase in medical travel and awareness of beauty are the key market drivers enhancing the breast implants market growth.
Source: Secondary and Primary Research, MRFR Database and Analyst Review
Silicone shells stuffed with silicone gel or sterile salt water (saline) make up a breast implant. Breast implants are man-made items (prostheses) that are surgically inserted into the breast during mammoplasty, a procedure for breast enhancement. Breast implantation is performed for a variety of causes, including to improve self-esteem and body image, for women who have undergone mastectomy (breast removal because of cancer), whose breast size has diminished owing to pregnancy, losing weight, or getting older, whose breasts are uneven, and for women whose breasts are large but not normal-sized. The rise in breast procedures globally is a major factor driving the market. Due to the desire of individuals to seem attractive and their readiness to spend cash to do so, particularly those who are older, the demand for breast augmentation and implantation has skyrocketed.
The market for breast implants is also expanding because of the increased amount of research being done to develop implants with improved endurance. In addition, the market has undergone a revolution thanks to under-the-muscle breast augmentation. Women increasingly favor under-the-muscle breast augmentation over the conventional technique since it requires less surgery. The market is anticipated to gain momentum from the quick uptake of minimally invasive breast augmentation. Since the product is expected to be approved, the market is predicted to have profitable growth potential. Considering this, this factor is projected to spur growth in the global market for breast implants. The key issues impeding the growth of the breast implant industry, however, are the post-surgery difficulties and hazards involved with the implant, as well as the expensive cost of the implant.
Additionally, there is much misinformation about breast implants' risks and side effects for women following surgery. However, if this limitation is overcome by educating women and dispelling their myths, it will help the worldwide breast implant industry. Additionally, there was a decrease in the overall amount of breast augmentation surgeries. Compared to other types of implants, gummy bear implantation has recently attracted much attention. The high level of crosslinking in these implants maintains the form of the implants and avoids wrinkles. This has substantially expanded its acceptance among women in society. Since silicone implants are safer than traditional implants, it is a significant development.
January 2024: A regenerative and aesthetics medicine establishment developing innovative technologies and products built on its non-animal-derivative collagen for tissue regeneration and organ production, CollPlant Biotechnologies, on January 27th disclosed its initiation of a pre-clinical trial to examine 3D-bioprinted, commercial-size, regenerative breast implants. At present, there are no commercial products that enable the regeneration of soft tissues such as the breast. Yehiel Tal, CollPlant's Chief Executive Officer, said that the company is glad about the development of their regenerative breast implants program thus far and the commencement of this important study. He further added that CollPlant's breast implants in progress are brilliant in that they are developed to restore breast tissue as well as have fundamental safety benefits. This would be a major revolution in the market that has maintained such a large demand yet has witnessed rising issues with safety over the last few decades. The main target of the research is to gain data that would then support the maximizing of the implant design and apply this design to a crucial large-animal study that is intended to be the subject of discussions with the FDA. In the US itself, hundreds of thousands of people each year witness negative events that vary from autoimmune symptoms to very serious breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). CollPlant's breast implants, made of the brand's proprietary plant-derived rhCollagen and other biomaterials, are anticipated to reproduce breast tissue without eliciting immune response and thus may offer a revolutionary alternative for aesthetic and reconstructive procedures, such as postmastectomy for cancer patients.
November 2023: An AbbVie company, Allergan Aesthetics, incorporates the immensely personal choice that patients experience when selecting breast surgery. The latest Natrelle® campaign, "For Every BODY," underlines patients and their diverse stories with new pictures and visual assets, which can be visited at alookforeverybody.com. The campaign displays how the Natrelle® breast implant portfolio can offer a personalized look for every curve, for every BODY, and every shape.
The market is largely driven by the increase in breast operations worldwide. The demand for breast implantation and enlargement has increased due to people's desire to look attractive and their willingness to spend money to do it, particularly those who belong to privileged organizations. The United States, Brazil, and Mexico have the greatest rates of breast implants surgeries. The International Society of Aesthetic Plastic Surgery estimates that more than 1.86 million breast augmentation procedures were carried out worldwide. This will accelerate the market's growth between 2024 and 2032. In addition, it is projected that the desire for a celebrity look among many women in nations like China and Japan would spur market CAGR expansion.
In comparison to 2017, when 1,677,319 breast augmentation operations were carried out globally, 1,862,506 treatments were carried out in 2018, according to the International Society of Aesthetic Plastic Surgery. This indicated an increase of 9.9%. The American Society for Aesthetic Plastic Surgery (ASAPS) reports that 313,735 breast augmentation operations were carried out in the U.S. alone in 2018, up from 300,378 treatments in 2017. The demand for breast augmentation goods will rise as a result.
Source: Secondary and Primary Research, MRFR Database and Analyst Review
It is also anticipated that introducing new goods and technology developments that improve vision would accelerate market expansion. The debut of Eve 4.0, a Digital Consultation Solution (DCS) that offers visualization tools to patients in Europe and Brazil contemplating breast reconstruction or augmentation, was announced by G.C. Aesthetics in June 2019. This likely boosts the regional markets' growth. The market for breast implants is also growing due to increasing research into creating implants with greater durability. AMSilk GmbH and POLYTECH Health & Aesthetics worked together to launch a clinical trial for the silk-coated breast implants SILKline in Europe in February 2018. The market is projected to have profitable growth prospects as a result of the anticipated product approval. Thus, it is anticipated that this aspect will accelerate Breast implants market revenue globally.
For industry participants in breast augmentation, emerging nations like China, Brazil, Mexico, and India provide substantial prospects. The rapid expansion of medical tourism, the expanding adult population (aged 20 and above), and rising disposable incomes all contribute to the rising demand for breast augmentation in these nations. Brazilians underwent the second-highest number of breast augmentation operations in 2018, according to ISAPS research. Brazil performed 14.7% of breast augmentation surgeries in 2018.
Based on product, the market segments of breast implants includes silicone implants, saline implants, smooth breast implants, and round implants. Silicone implants segment dominated the breast implants market revenue in 2022. This is because these implants frequently resemble genuine breast tissue. For instance, a gummy implant gives the rebuilt breast a natural contour. Additionally, this product category has no danger of immune system diseases. Due to their soft texture, silicone implants are anticipated to maintain their supremacy during the predicted period. This characteristic reduces the possibility of developing tough scar tissue near the implantation. Gummy implants also have a reduced chance of wrinkle formation.
Figure 2: Breast Implants Market, by Product, 2022 & 2032 (USD Billion) 
Source: Secondary and Primary Research, MRFR Database and Analyst Review
Based on shape, the breast implants market segmentation includes anatomical and round. Round-shaped implants segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. They are excellent candidates for breast augmentation due to their rounded contours. These gadgets frequently resemble compressed spheres. As a result, there was a tremendous demand for these items, which helped the industry expand. Round implants are symmetrical and do not cause any issues while rotating the implant. As a result, circular implants are preferred over anatomical implants by even doctors. Arion Laboratories offers a wide variety of round breast implants. For instance, this business produces Monobloc Silicone, a spherical implant.
Based on application, the breast implants market data includes breast reconstruction, and breast augmentation. The most prominent and fastest-growing sub-segment in the next years is breast augmentation. While breast restoration is done to restore function and a normal look after surgery due to cancer or to alter the positioning of breasts after a birth difference, breast augmentation operations are expressly designed to boost the present breast volume. Due to a large rise in the number of women selecting this surgery, breast augmentation operations are predicted to develop rapidly throughout the projected time.
The breast implants industry based on end-user, includes clinics, hospitals, cosmetics centers, ambulatory surgical centers and others. In 2022, cosmetic centers represented the greatest revenue share. The expanding cosmetic industry's development brings this on to improve visual attractiveness. Breast augmentation treatments used in cosmetic surgery improve this organ's look. A prominent technique in the realm of cosmetic surgery is breast implantation. Compared to other types of implants, they feel more like real breast tissue, which is the key factor in why most women choose them over other forms.
News:CollPlant and Stratasys inked a combined development and commercialization agreement to advance the development of bioprinting technology. The partnership will pair CollPlant's rhCollagen-based bio-inks with Stratasys' P3 technology-based bioprinter. P3, often called programmable photopolymerization, is a digital light processing technical advancement meant to mass produce usable end-use components. The initial project of the partnership, which focuses on the growth of industrial-scale manufacturing of CollPlant's regenerative breast implants, will be at the forefront of the new bioprinter utilized with CollPlant's bio-inks. CollPlant intends to start a follow-up large-animal research utilizing commercial-size implants in the second half of 2023 to support the next human investigations and product commercialization.
By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Breast Implants market, accounted for USD 1.09 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. Breast augmentation is one of the top 5 cosmetic surgeries in the United States, according to the American Society of Plastic Surgeons (ASPS). Over 313,378 breast augmentation surgeries were carried out in the U.S. in 2018, according to the ASPS. A substantial number of these instances are predicted to support the market's growth over the next years. Regulations governing procedure reimbursement are advantageous for the North American breast reconstruction market. Over the past 20 years, there has been a marked rise in the incidence of breast cancer. Furthermore, according to the Canadian Cancer Society, breast cancer is the most frequent cancer in Canadian women.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: Breast Implants Market Share By Region 2022 (%)
Source: Secondary and Primary Research, MRFR Database and Analyst Review
Due to the large number of women undergoing cosmetic treatments and the existence of prominent players in the Region, the Europe market of breast implants is anticipated to account for a sizeable market share. The European Union actively promotes structured screening programs for various illnesses, including breast cancer. The area's utilization of breast implants is rising due to these activities. Due to the swift development of technology in design, material, and fill volumes, the production of sophisticated breast implants has also evolved, reducing negative patient outcomes such as implant wrinkling and rippling. The Breast implants industry is seeing fresh growth because of the existence of skilled plastic surgeons in the area and rising product innovation. Moreover, UK market of breast implants held the largest market share, and the Germany market of breast implants was the fastest growing market in the region.
The Asia breast implants market is anticipated to develop at the fastest rate. Increased breast cancer incidence rates in the area and a rise in breast augmentation operations are factors that have contributed to the growth of the market. On the other side, it is anticipated that dangers related to breast implants, such as pain and infection, may have a detrimental effect on the sector. The demand for cosmetic surgery has significantly increased due to the Asia Pacific region's fast economic growth. Further, the China market of breast implants held the largest market share, and the India market of breast implants was the fastest growing market in the region.
Breast Implants Key Market Players & Competitive Insights
Major market players are investing a lot of money in R&D to expand their product portfolios, which will spur further market growth for the Breast Implants industry. With significant industry changes, including new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market development are also undertaking various strategic activities to expand their presence. To grow and remain in a market that is becoming more and more competitive, Breast Implants industry competitors must provide affordable products.
Manufacturing locally to cut operational costs is one of the main business tactics used by the Breast Implants industry to serve customers and increase the market sector. The Breast Implants industry has recently given medicine some of the most important advantages. The Breast Implants market major player such as Allergan (Actavis), Sientra Inc., G.C. Aesthetics, Mentor Worldwide LLC, Establishment Labs S.A., Polytech Health & Aesthetics GmbH, GROUPE SEBBIN SAS, Hans Biomed Co. Ltd., Laboratoires Arion, Shanghai Kangning Medical Supplies Ltd., CEREPLAS), and others are working on expanding the market demand by investing in research and development activities.
Female aesthetics firm GC Aesthetics creates, produces, and sells silicone breast implants for women. The debut of PERLE, a next-generation smooth breast implant with a unique surface method called BioQ, has been officially announced by GC Aesthetics Inc., a silicone implant maker, for October 2020. Due to the increase in demand for silicone breast implants, the market is anticipated to grow throughout the projection period.
The American pharmaceutical business Allergan plc, which has its headquarters in Ireland, buys, develops, produces, and sells name-brand medications and medical equipment. For instance, Allergan plc's NATRELLE INSPIRA Cohesive implants, a new entry in the category of gummy breast implants, earned U.S. FDA clearance in 2016.
Key Companies in the market of Breast Implants include
Breast Implants Industry Developments
June 2022: In response to the needs of breast reconstruction, Coll Plant announced the beginning of a research in large animals for its 3D bio-printed regenerative breast implant programme.
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â 2032 : USD 4.67 billion |
| Â Â CAGR | Â Â 2024-2032: 6.65% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2022 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Product, Shape, Application and End-User |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Allergan (Actavis), Sientra Inc., GC Aesthetics, Mentor Worldwide LLC, Establishment Labs S.A., Polytech Health & Aesthetics GmbH, GROUPE SEBBIN SAS, Hans Biomed Co. Ltd., Laboratoires Arion, Shanghai Kangning Medical Supplies Ltd., CEREPLAS, Ideal Implant Inc., Shanghai Kangning Medical Device Co. Ltd. and Guangzhou Wanhe Plastic Materials Co. Ltd. |
| Â Â Key Market Opportunities | Â Â Advances in technology and improvements in designs and construction of breast implants |
| Â Â Key Market Drivers | Rise in awareness of breast surgeries Rise in medical tourism, rising beauty consciousness |
Frequently Asked Questions (FAQ) :
key players in the global breast implants market are Allergan (Actavis), Sientra Inc., GC Aesthetics, Mentor Worldwide LLC, Establishment Labs S.A., Polytech Health & Aesthetics GmbH, GROUPE SEBBIN SAS
Breast Implants Market has chances of attaining 6.65% CAGR during the forecast period of 2024 to 2032.
North America would be the fastest-growing one in the Breast Implants Market
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
